Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: Assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial

American Heart Journal

Volumn 166, Issue 3, 2013, Pages 481-487

  Mancini, G B John ^a   Hartigan, Pamela M ^b   Bates, Eric R ^c   Chaitman, Bernard R ^d   Sedlis, Steven P ^e   Maron, David J ^f   Kostuk, William J ^g   Spertus, John A ^h   Teo, Koon K ⁱ   Dada, Marcin ^j   Knudtson, Merril ^k   Berman, Daniel S ^l   Booth, David C ^m   Boden, William E ⁿ   Weintraub, William S ^o  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^g UNIVERSITY OF WESTERN ONTARIO   (Canada)

^h UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

ⁱ MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^j HARTFORD HOSPITAL   (United States)

^k UNIVERSITY OF CALGARY   (Canada)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m UNIVERSITY OF KENTUCKY   (United States)

ⁿ UNIVERSITY AT BUFFALO   (United States)

^o CHRISTIANA CARE HEALTH SYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CORONARY ARTERY; DEATH; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; OPTIMAL MEDICAL THERAPY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; STABLE ANGINA PECTORIS; STENOSIS; THERAPY; VASCULAR DISEASE;

ANGINA PECTORIS; CORONARY ANGIOGRAPHY; CORONARY VESSELS; FEMALE; HEART VENTRICLES; HOSPITALIZATION; HUMANS; MALE; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; STROKE VOLUME; SURVIVAL ANALYSIS;

EID: 84883820265     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.07.007     Document Type: Article

References (14)

1. W.G. Austen, J.E. Edwards, and R.L. Frye A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association Circulation 51 1975 5 40
2. R.M. Califf, H.R. Phillips, and M.C. Hindman Prognostic value of a coronary artery jeopardy score J Am Coll Cardiol 5 1985 1055 1063
3. D. Andreini, G. Pontone, and S. Mushtaq A long-term prognostic value of coronary CT angiography in suspected coronary artery disease JACC Cardiovasc Imaging 5 2012 690 701
4. B.J. Chow, G. Small, and Y. Yam and the CONFIRM Investigators. Incremental prognostic value of cardiac computed tomography in coronary artery disease using CONFIRM: COroNary computed tomography angiography evaluation for clinical outcomes: an InteRnational Multicenter registry Circ Cardiovasc Imaging 5 2011 463 472
5. C.J. Pepine Residual risk for secondary ischemic events in patients with atherothrombotic disease: opportunity for future improvements in patient care Ann Med 42 2010 19 35
6. W.E. Boden, R.A. O'Rourke, and K.K. Teo Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
7. D.J. Maron, W.E. Boden, and R.A. O'Rourke Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial J Am Coll Cardiol 55 2010 1348 1358
8. G.B.J. Mancini, E.R. Bates, and D.J. Maron Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial Circ Cardiovasc Qual Outcomes 2 2009 320 327
9. G.B.J. Mancini, P.M. Hartigan, E.R. Bates on behalf of the COURAGE Investigators and Coordinators Disease progression and residual risk of cardiovascular events while on optimal medical therapy: observations from the COURAGE trial Circ Cardiovasc Interv 4 2011 545 552
10. Cox DR Regression models and life tables. JRSSB 172;34:187-220.
11. E.L. Kaplan, and P. Meier Nonparametric estimation for incomplete observations JASA 53 1958 457 481
12. J.M. Lachin Introduction to sample size determination and power analysis for clinical trials CCT 2 1981 93 113
13. International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA). NCT01471522.
14. B. Daneault, P. Benereux, and A.J. Kirtane Comparison of 3-year outcomes after primary percutaneous coronary intervention in patients with left ventricular ejection fraction < 40% versus ≥ 40% (from the HORIZONS-AMI Trial) Am J Cardiol 111 2013 12 20